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Abstract
Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), has become a worldwide pandemic. Ginger (Zingiber officinale) is a rhizome, which is commonly used for
culinary and medicinal purposes. In Indonesia, ginger is taken as traditional medicine by processing it into a drink
known as jamu. The present study aimed to assess and evaluate the bioactive compounds in ginger that can be used in
drug design for treating COVID-19. The crystal structure of the SARS-CoV-2 main protease (Mpro) was generated from
a protein sequence database, i.e., Protein Data Bank, and the bioactive compounds in ginger were derived from the
existing compounds library. Mpro is involved in polyprotein synthesis, including viral maturation and nonstructural protein
gluing, making it a potential antiviral target. Furthermore, the bioactive compounds in ginger were analyzed using
Lipinski’s rule of five to determine their drug-like molecular properties. Moreover, molecular docking analysis was
conducted using the Python Prescription 0.8 (Virtual Screening Tool) software, and the interaction between SARS-CoV-2
Mpro and the bioactive compounds in ginger was extensively examined using the PyMOL software. Out all of the 16
bioactive compounds that were docked successfully, 4-gingerol, which has the lowest binding energy against SARSCoV-2 Mpro, as per the virtual screening results, was proven to have the most potential as a viral inhibitor of SARSCoV-2.
Keywords: COVID-19, Mpro, molecular docking, SARS-CoV-2, Zingiber officinale

processing and releasing the translated nonstructural
proteins. Both Mpro and Plpro are essentially the focus of
drug design and development against the ongoing COVID
pestilences, including MERS-CoV and SARS-CoV. The
foremost accessible crystal structure of the COVID-19
protein is Mpro, which was identified and published in
February 2020 [3]. In contrast to MERS-CoV, coronavirus Mpro forms a phylogenetic group with SARS-CoV.

Introduction
Since the first case reported in Wuhan, Hubei Province,
Central China, coronavirus disease 2019 (COVID-19)
has spread rapidly to over 200 countries around the
world. The latest category of coronavirus, which is
called severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) [initially recognized as 2019 novel
coronavirus (2019-nCoV)], is responsible for this pandemic [1]. At present, the newly mutated SARS-CoV-2
has caused more than 1.5 million deaths, with more than
67 million declared cases around the world, representing
a severe danger to general well-being [2].

During the aforementioned virtual screening study, several medications consisting of an expansive range of
antivirals (e.g., ribavirin and telbivudine), vitamins, and
drugs that act systemically, were selected. Significantly,
ribavirin was utilized in treating the different stages of
SARS-CoV. An earlier investigation conducted by
Kandeel and Al-Nazawi [3] extensively focused on the
COVID-19 Mpro structure and discovered the stored

Coronavirus polyproteins encode two proteases, namely,
the papain-like protease (Plpro) and the main protease
called 3C-like protease (Mpro), which correlate while
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medications that are appropriate for reuse against the
Mpro virus along with the provision of a medication list,
which can be consolidated and utilized for the treatment
of COVID-19.
In Indonesia, treating oneself with traditional herbal
medicines is a part of the belief-system that has given
adequate results sometimes. Indonesians have handed
down the culture of consuming traditional concoctions
from generation to generation; this is particularly true
for those who live in or come from Java [4]. A popular
example of a traditional herbal remedy in Indonesia is
jamu, which is the herbal medicine made from natural
materials. Indonesians consume herbs to improve their
stamina, energy, and endurance to prevent several diseases [5]. Ginger (Zingiber officinale), which is a typical and broadly utilized spice, is one of the ingredients
used to make herbal medicines. Ginger has many different chemical components, including poly-saccharides,
organic acids, raw fiber, phenolic compounds, terpenes,
and lipids. The medicinal advantages of ginger are fundamentally credited to its phenolic compounds, e.g.,
gingerols and shogaols. The conducted analyses have indicated that ginger has numerous medicinal properties,
such as antimicrobial, cardiovascular protection, antidiabetic, antioxidant, anti-inflammatory, anticancer, neuroprotective, and respiratory protection [6].
Accordingly, this study employed the SARS-CoV-2
protease structure, obtained from Protein Data Bank
(PDB), and ligands, obtained from the PubChem database, along with some computer simulations, such as
molecular docking analysis and molecular dynamics
simulations, which would illustrate how Mpro in the
SARS-CoV-2 virus behaved when exposed to different
chemical compounds known for their 3C-like protease
inhibitor action and antiviral activity. This research is
expected to improve the scientific aspects of jamu, particularly ginger, in Indonesia.

Methods

GC-376 as standards, were compiled from the PubChem
database (Table 1) to obtain samples in the structure
data format (.sdf). Subsequently, energy minimization
was conducted and .sdf samples were converted into a
.pdb format. In Python Prescription 0.8 (PyRx; Virtual
Screening Tool) software, energy minimization was
performed for all molecules and completed by utilizing
OpenBabel with the default parameters. PyRx is a free
software used to perform virtual screening from any
platform, and it is effective in each process.
Virtual screening. The identification of small
molecules in SARS-CoV-2 Mpro was performed via
molecular docking analysis by inputting 16 chemical
compounds in ginger and using the AutoDock Vina
1.1.2 program on PyRx. This experiment was conducted
by applying a standard docking validation method
because it aimed to identify the best ligands to bind the
target protein with a default exhaustiveness value of 8.
Comparing the binding energy of the standard ligand
with that of the lead compounds was a good protocol
that could show the correctness of the docking method
[10]. However, other parameters, such as the X-ray
crystal structure of the protein, LogP, hydrogen bond
acceptors, hydrogen bond donors, number of rotational
bonds, and volume of the molecule, should also be
considered. Furthermore, Lipinski’s rule of five was
utilized to prove the potency of compounds with low
binding affinities and drug-like molecular properties.
Table 1. List of Compounds Derived from Zingiber
officinale
Compound Name

Compound ID

Citation

Remdesivir (standard)

121304016

[3]

Inhibitor GC-376 (standard)

71481119

[3]

4-Gingerol

46901319

[8]

6-Gingediol

101660275

[8]

6-Gingerol

442793

[9]

6-Shogaol

Sample retrieval. The three-dimensional (3D) crystal
structure of the SARS-CoV-2 (COVID-19) main
protease with inhibitor GC-376 was derived in.pdb
format from PDB with Protein ID: 6WTT. It was used
as it is well annotated in the database and has a good
resolution (2.15 Å) and no mutation. This model was
employed because it has the largest number of modeled
non-hydrogen atoms in the deposited model (7,430) and
the most recent release date (May 2, 2020). Moreover,
the 3D structure of the target protein was sterilized
using the PyMOL software to remove the original
ligand. Information about the content of bioactive
compounds in Zingiber officinale was obtained from
Sonale and Kadimi [7], Kharisma, Ansori, and Nugraha
[8], and Mao et al. [9]. Approximately 16 compounds of
Zingiber officinale, including remdesivir and inhibitor
Makara J. Sci.
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5281794

[9]

8-Gingediol

101941698

[7]

8-Gingerol

168114

[8]

10-Gingerol

168115

[9]

α-Curcumene

92139

[9]

α-Farnese

5281516

[9]

β-Bisabolene

10104370

[9]

β-Sesquiphellandrene

12315492

[9]

162952

[8]

Methyl-6-Gingerol

70697235

[7]

Methyl-6-Shogaol

91721066

[7]

Zingerone

31211

[8]

Zingiberene

92776

[9]

Gingerdione

September 2021  Vol. 25  No. 3

164 Wijaya, et al.

Molecular visualization. The PyMOL software, which is
a molecular graphic tool that has been broadly applied to
show the 3D images of molecules, nucleic acids, proteins,
and surfaces, was employed to visualize the docking
results and the 3D structure of the target protein [11].
This software was used to edit molecules data
annotation and make motion pictures. Molecular
visualization was accomplished by showing the 3D
protein structure in animated and surface forms, and
staining selection was performed to differentiate the
domains between the chains on the target protein and
the type of ligands attached.
Molecular dynamics simulations. The simulation
method that mimicked biological processes was
provided by molecular dynamics simulations (i.e.,
virtual cells). Through this simulation, the stability of an
interaction could be assessed under particular conditions,
such as temperature and solvent type. One of the most
difficult challenges to molecular modeling is the proper
handling of ligands, and for this reason, automated tools
were highly favored. Several methodologies or software
programs for estimating molecular dynamics force
fields claim to have parameters consistent with different
force fields. One of them is CABS-flex 2.0
(http://212.87.3.1 2/CABSflex2/index), in which the
online simulation of molecular dynamics was performed
for the best leads as it provided a rapid modeling
approach for simulating the flexibility of protein
structures. CABS-flex 2.0 is based on the CABS model,
a well-known coarse-grained protein modeling tool—
CABS design and applications, which can produce
protein dynamics at a low computational cost (3 orders
of magnitude), albeit with a significant resolution
reduction. The purpose of utilizing this tool was to
calculate the root mean square fluctuation (RMSF)
indication of protein flexibility. During molecular
dynamics simulations, the amplitude of atomic motions
was monitored by this tool. The aforementioned factors
should be documented in this manner, particularly the
primary factor that yields the RMSF of 1–3 Å, which
indicates the stability of peptides. The distance restraint
generator, additional distance restraints, and advanced
simulation settings will be set to the default values.

Results and Discussion
The chemical compounds in ginger (Zingiber officinale), inhibitor GC-376 (naturally attached ligand to the
Mpro crystal structure), and remdesivir were obtained
from the PubChem database. The sample data consisting
of the target compound’s 3D structure in .sdf were converted into the .pdb format. Therefore, the 3D structure
could be used for further analysis. The structure selection of the target compound is displayed in a two-
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dimensional (2D) representative form and colored based
on the building blocks of the PyMOL software (Figure
1).
The chemical compounds in ginger are predicted to be
drug-like molecules on the server (scfbio-iitd.res.in/
software/drugdesign/lipinski.jsp) using Lipinski’s rule
of five, which aids in differentiating between the druglike and non-drug-like particles based on their vital
atomic characteristics [12]. Lipinski’s rule of five foresees a high likelihood of success or failure due to the
drug’s similarity for molecules by meeting at least two
of the five rules. The rule consists of the following
items: atomic mass should be less than 500 Da, lipophilicity (LogP) must be less than 5, donor hydrogen
bonds must be less than 5, hydrogen bond acceptors
must be less than 5, and molar refractivity must be between 40 and 130. These rules can assist in early preclinical development and help evade the expansive preclinical and late-stage setbacks [13, 14]. In this study,
the predictions show that all chemical compounds in
ginger are drug-like molecules and Lipinski’s rule of
five is not violated (Table 2). Thus, these chemical
compounds can enter the next stage of analysis to decide the binding affinity of the target protein.
In this investigation, the chemical compounds in ginger
were taken as ligands, remdesivir and GC-376 as
standards, and SARS-CoV-2 Mpro as target. Docking
simulations for all of these compounds were conducted
by maximizing the Vina Search Space in the PyRx
software with grid docking centers X = −15.905, Y =
30.8490, Z = 11.9730 and dimensions (Å) X = 67.2865,
Y = 92.3788, Z = 97.9204. The chemical compound in
ginger with the lowest binding energy against SARSCoV-2 Mpro, as per the virtual screening results, was
determined to be 4-Gingerol (Table 3). Molecular
binding assay was conducted to identify molecules,
structural parts that distinguish the possible binding
modes, and energetic parts that predict the binding
scores [15]. Proteins were prepared via the PyMOL
software to remove water molecules and their original
ligands because they can clash with the protein [16].
Ligands with the most negative binding energy can
affect the biological activity of the target protein, which
is in line with the purpose of this study. Henceforth, it
aims to predict the compound with the most potential as
a viral inhibitor of SARS-CoV-2 Mpro. Given that atoms
in nature will be commonly found in the structure with
the least energy, their final configuration must likewise
have low energy. Understanding these properties is
essential in the judicious plan of potential inhibitors [17,
18].
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Figure 1. Two-dimensional (2D) Structures of Ginger and Remdesivir Chemical Compounds from the PubChem Database
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Table 2. Prediction Results of Drug-like Molecules Derived from the Chemical Compounds in Ginger

Molecular
Mass (Da)

High Lipophilicity
(LogP)

Hydrogen
Bond Donors

Hydrogen
Bond Acceptors

Molar
Refractivity

4-Gingerol

266

2.453599

2

4

73.518578

6-Gingediol

196

3.025599

3

4

83.752365

6-Gingerol

294

3.233799

2

4

82.752571

6-Shogaol

276

4.038999

1

3

81.268776

8-Gingediol

324

3.805798

3

4

92.986359

8-Gingerol

322

4.013999

2

4

91.986565

10-Gingerol

350

4.7942

2

4

101.220558

α-Curcumene

202

4.844920

0

0

68.258987

α-Farnese

204

5.201500

0

0

70.992981

β-Bisabolene

204

5.035399

0

0

68.902977

β-Sesquiphellandrene

204

4.891300

0

0

68.832977

Gingerdione

292

3.441999

1

4

81.752777

Methyl-6-Gingerol

308

3.536799

1

4

87.639771

Methyl-6-Shogaol

290

4.341999

0

3

86.155975

Zingerone

194

1.9224

1

3

53.660789

Zingiberene

204

4.891299

0

0

68.832977

Compound Name

Table 3. Molecular Docking Results

Ligand

Target

Binding Energy (kcal/mol)

Mpro

−8.3

M

pro

−7.8

M

pro

−7.3

M

pro

−6.8

M

pro

−6.7

M

pro

−6.5

M

pro

−6.4

M

pro

−6.3

M

pro

−6.3

8-Gingerol

M

pro

−6.2

6-Gingediol

Mpro

−6

M

pro

−6

M

pro

−5.9

M

pro

−5.9

M

pro

−5.7

M

pro

−5.7

M

pro

−5.6

M

pro

−5.6

Remdesivir (standard)
Inhibitor GC-376 (standard)
4-Gingerol
β-Bisabolene
Gingerdione
Methyl-6-Gingerol
6-Shogaol
6-Gingerol
Methyl-6-Shogaol

Zingerone
10-Gingerol
α-Farnese
8-Gingediol
α-Curcumene
β-Sesquiphellandrene
Zingiberene
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In this investigation, Mpro was utilized because it is an
essential enzyme of coronaviruses and plays an
important role in mediating viral replication and
transcription. Furthermore, the main protease is
important in the viral life cycle and has no close relation
to homologous sequences in humans [19]. Molecular
visualization of the docking results of this study was
accomplished using the PyMOL software for staining
and structural selection (Figure 2). All of the
compounds were mostly docked at the same sites and
located in Chain B of the target protein.
The target protein was visualized on a transparent
surface and a animated structure, with the red raspberry
color denoting Chain A, blue marine color denoting
Chain B, and pale yellow color denoting Chain C
(Figure 3). The chemical combinations with the least
binding energy were extensively examined to determine
the position of their molecular interactions, and the
types of bonds formed were visualized using the
ProteinPlus web portal in the PoseView program. The
PoseView program generates 2D diagrams of
complexes with known 3D structures using chemical
structure drawing rules [20]. The direct bonds between
the protein and ligands were denoted by dashed lines,
whereas the interplaying protein residues and ligands
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were illustrated in the structural diagrams. Furthermore,
the spline sections represented the hydrophobic portions
of the ligands and the communicating amino acids
represented the hydrophobic interactions. To derive the
structural diagrams and modify their layouts, the 2D
drawing package was utilized [21]. The estimations of
the interactions between molecules were completed by
applying the atom type and basic geometric-criteriabased built-in interaction model. 4-gingerol compounds
interact in the SARS-CoV-2 Mpro domain with
hydrophobic bonds at the Phe294, Asn151, Gln110, and
Val104 positions and hydrogen bonds at the Asn151,
Thr111, and Asp153 positions (Figure 3). The
atomically resolved structure at the ligand and protein
interface is required to launch a novel strategy for drug
design and development. The maintenance of atom sites
in this approach was accomplished using diverse
biophysical factors, e.g., molecular weight, hydrogen
bonds, size, hydrophobic interactions, and shape. In the
open conformational environment of protein structures,
the reduced intermolecular interactions, including
hydrogen bonding and hydrophobic interactions,
stabilize the energetically-favored ligands. Prioritizing
hydrophobic interactions over hydrogen bonding leads
to tight binding [22].

Figure 2. Molecular Visualization of Bioactive Compounds in Ginger Binding to Mpro using the PyMOL Software
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Figure 3. Structure of the Target Protein (SARS-CoV-2 Mpro) and its Chemical Interactions with 4-gingerol. Visualization of
the SARS-CoV-2 Mpro Target Protein using Transparent and Animated Surfaces. Staining Selection Performed using the PyMOL Software differentiates between the Chains (A, B, and C) of the Protein

SARS-CoV-2 Mpro interplays with the top three ligands
identified by molecular docking analysis, namely,
remdesivir, 4-gingerol, and β-bisabolene (Figure 4). No
hydrogen bond was detected between β-bisabolene and
the target protein. Remdesivir bonded with five different
amino acid residues, i.e., Asp216, Phe3, Lys137, Gly138,
and Lys5. Similarly, 4-gingerol bonded with five amino
acids, i.e., Lys90, Lys88, Gly79, Arg105, and Ser81. In
both remdesivir and 4-gingerol, hydrogen bonds
occurred between the ligand and the target protein.
Hydrogen bonds occur commonly in nature and are
essential for protein–ligand interactions, protein folding,
Makara J. Sci.

and catalysis. By promoting molecular interactions,
hydrogen bonds enhance a variety of biological
activities; they are usually considered to facilitate
protein–ligand binding [23].
Figure 5 shows the target protein with its ligands
presented in a 3D structure and its 2D fluctuation plots.
The fluctuation plot exhibits the residue-by-residue
variations that were observed during the simulation.
When dealing with multichain proteins, each chain is
plotted individually. Because these ligands are bound on
Chain B, only the plot from Chain B is presented. The
September 2021  Vol. 25  No. 3
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x-axis of the plot shows the RMSF values (Å), whereas
the y-axis shows the amino acid residue index. Protein
flexibility and dynamics will change depending on
conformation, as shown in Figure 5. Molecular docking
analysis using Mpro showed that 4-gingerol has the
lowest free energy, and its protein fluctuation remains

169

below the RMSF criterion of 1–3 Å. Consequently, 4gingerol is considered to have a stable conformation.
Moreover, the Mpro–4-gingerol complex is detected in
residues 49–51 and 191. Any discrepancy in RMSF
indicates that the differences in ligand conformation
will eventually affect the protein flexibility.

Figure 4. 2D Diagrams of the Interactions of SARS-CoV-2 Mpro with Remdesivir, 4-gingerol, and β-bisabolene, Visualized
using the LigPlus Software [24]

Figure 5. 3D structure and Fluctuation Plot of SARS-CoV-2 Mpro with 4-gingerol (CABS-flex)

Makara J. Sci.
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As stated in FooDB, 4-gingerol belongs to the gingerols
class of compounds. Gingerols are compounds that have
a gingerol moiety with the structural definition “4hydroxy-3-methoxyphenyl group” replaced at the C6
carbon atom by “5-hydroxy-alkane-3-one.” 4-Gingerol
is insoluble in water and has low acidity. Ginger contains 4-Ggingerol, making it a possible biomarker for
the intake of this dietary product.
Protein–ligand connections are essential for all cycles
that occur in all life forms. The ligand mediates signal
transmission through atomic complementarity, which is
the basis for all life forms. These substance reactions
include biological recognition at the subatomic level.
Protein enhancement depends to a limited extent on the
development of particular sites intended to tie the small
molecular ligands with affinities tailored to the requirements of the cell [25]. 4-Gingerol can be a candidate for
drug design and development for the treatment of
COVID-19 because it can bind to SARS-CoV-2 Mpro
with the lowest binding energy and interact via hydrogen and hydrophobic bonds (Figure 3). 4-Gingerol also
satisfies Lipinski’s rule of five and can be categorized
as a drug-like molecule because it has an atomic mass of
266 Da, LogP of 2.453, two hydrogen bond donors, four
hydrogen bond acceptors, and a molar refractivity of
73.518 (Table 2).
Molecular dynamics simulations showed that 4-gingerol
could interact more effectively with SARS-CoV-2 Mpro,
indicating that it has therapeutic prospects for the treatment of SARS-CoV-2 infections by inhibiting Mpro,
leading to the inactivation and consequent failure of
virion assembly. The comprehensive virtual screening
yielded annotations indicating that compounds derived
from ginger are the best leads. In this sense, the apparent reusability of bioactive compounds Zingiber officinale as SARS-CoV-2 Mpro inhibitors has been highlighted. Before clinical trials, both in vivo and in vitro
studies are strongly recommended to determine the
therapeutic effectiveness of the aforementioned experimentally-created ligands.

Conclusion
In this study, the bioactive compounds in ginger were
subjected to several experiments, such as Lipinski’s rule
of five, molecular analysis, molecular dynamics simulations, and chemical interaction evaluation, with M pro as
the protein target of SARS-CoV-2. Among all the ligands, 4-gingerol was determined to be the best because
it exhibited outstanding stability during molecular docking analysis and molecular dynamics simulations. Further investigation, particularly pathway prediction employing the Stitch database, is recommended, and the
potential of 4-gingerol must be proven through in vitro
and in vivo analyses to obtain the right formula. Thus,
jamu made from ginger and turmeric has bioactive
Makara J. Sci.

compounds. To further validate this research, analyses
could be performed to determine which atoms from the
protein and ligand bonded.
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